Procurement Summary
Country: USA
Summary: Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
Deadline: 23 Jan 2025
Posting Date: 26 Feb 2022
Other Information
Notice Type: Tender
TOT Ref.No.: 63757571
Document Ref. No.: PAR-22-114
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Tender are invited for Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
CFDA Number : 93.393 -- Cancer Cause and Prevention Research93.394 -- Cancer Detection and Diagnosis Research93.395 -- Cancer Treatment Research93.396 -- Cancer Biology Research93.397 -- Cancer Centers Support Grants93.398 -- Cancer Research Manpower93.399 -- Cancer Control
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Jan 23, 2025
Posted Date : Feb 25, 2022
Description: The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technic...
Documents
Tender Notice